Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI
Study Details
Study Description
Brief Summary
The investigators will assess the ability of ultrasound (US) to measure liver stiffness (cirrhosis) and liver fat content (steatosis).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Non-invasive monitoring of liver fibrosis using magnetic resonance imaging (MRI) can help determine which patients will most benefit from interventional therapies to help reverse the condition. Similarly, quantitative assessment of liver fat content using MRI can assist physicians in identifying patients at risk for hepatic steatohepatitis.
Due to the widespread dissemination of US machines and their relative lower cost compared to other imaging modalities, e.g. MRI, the ability of US to assess these parameters widens diagnostic availability.
Patients who have undergone an MRI exam to assess liver stiffness (cirrhosis) and/or liver fat content (steatosis) will be asked to undergo an US exam to assess the same parameters. The cirrhosis and steatosis measurements obtained from both exams will be compared. If US-based measurements of liver stiffness and/or liver fat content are shown to be reproducible and accurate when compared to MRI values (will be used as the gold standard), US may become the first-line diagnostic test for these liver conditions.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Patients with Liver Fibrosis Measurement Group1: Patients will undergo an Ultrasound to correlate fibrosis measurements obtained using standard-of-care MRI. |
Diagnostic Test: Ultrasound
Patients will undergo a standard liver US protocol for approximately 15 minutes.
Other Names:
|
| Patients with Liver Steatosis Measurement Group 2: Patients will undergo an Ultrasound to correlate steatosis measurements obtained using standard-of-care MRI. |
Diagnostic Test: Ultrasound
Patients will undergo a standard liver US protocol for approximately 15 minutes.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Discriminatory value (AUC) of US in assessing liver stiffness [an estimated time of 30 minutes]
Discriminatory value (the ability of the test to diagnose disease from healthy) will be calculated using nonparametric receiver operating characteristic (ROC) curve analysis. Sensitivity (i.e. true positive rate: the ability of a test to correctly identify patients with the disease being investigated) is plotted on the y axis and 1-specificity (i.e. false positive rate: the test incorrectly identifies patients who do not have the disease being investigated as having the disease) will be plotted on the x-axis. Cutoff points of US liver stiffness values will be chosen to create the graph of sensitivity versus 1-Specificity, i.e. the ROC curve, and the area under the curve (AUC) is used to determine how well US discriminates patients with liver stiffness from patients without liver stiffness. The closer the AUC gets to 1, the more discriminatory the test. An AUC=0.5 is a test that is right 50% of the time, and is no better than flipping a coin.
- Discriminatory value (AUC) of US in assessing liver fat content [an estimated average of 30 minutes]
Discriminatory value (the ability of the test to diagnose disease from healthy) will be calculated using nonparametric receiver operating characteristic (ROC) curve analysis. Sensitivity (i.e. true positive rate: the ability of a test to correctly identify patients with the disease being investigated) is plotted on the y axis and 1-specificity (i.e. false positive rate: the test incorrectly identifies patients who do not have the disease being investigated as having the disease) will be plotted on the x-axis. Cutoff points of US liver fat content values will be chosen to create the graph of sensitivity versus 1-specificity, i.e. the ROC curve, and the area under the curve (AUC) is used to determine how well US discriminates patients with liver fat content from patients without liver fat content. The closer the AUC gets to 1, the more discriminatory the test. An AUC=0.5 is a test that is right 50% of the time, and is no better than flipping a coin.
Secondary Outcome Measures
- US Elastography Stiffness [an estimated average of 30 minutes]
MRI tissue stiffness is reported in shear modulus (S), while US uses Young's modulus (Y). Since Y = 2*(1+m)*S, where m is the Poisson's ratio for the material, and since that ratio is between 0.49 and 0.50 for tissue, the US measurements should be three times that of the MRI ones. In particular, treating the MRI measurements as the reference, theory predicts a linear relationship: Y = 0 + 3*S which can be tested with a linear regression model. The most straightforward means is by calculating the expected Young's modulus values for US from the MR measurements, and regressing them on the observed US measurements. Both US and MRI values are given below.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
participants who have a clinical indication for a standard of care MRI exam that included assessment of the liver
-
participant is at least 18 years of age
Exclusion Criteria:
-
Participants unable to take part in the decision making process on whether to consent to the trial
-
Patients with previous chemoembolization or other focal liver therapies to the liver (* NOTE: for liver transplant patients, this criterion is only applicable to the transplanted liver)
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Stanford University Hospital | Stanford | California | United States | 94305 |
| 2 | Stanford University | Stanford | California | United States | 94305 |
Sponsors and Collaborators
- Stanford University
Investigators
- Principal Investigator: Aya Kamaya, MD, Stanford University
- Principal Investigator: Andreas Loening, MD, Stanford University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 38649